Trial Profile
A single dose, open-label study assessing pharmacokinetics, safety and tolerability of hydromorphone after a single oral administration to Japanese volunteers without an opioid antagonist.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Dec 2015
Price :
$35
*
At a glance
- Drugs Hydromorphone (Primary)
- Indications Pain
- Focus Adverse reactions; Pharmacokinetics
- 07 Dec 2015 New trial record